{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:53Z","timestamp":1790371253178,"version":"4.1.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01343","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:49:39Z","timestamp":1576730979000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["The Muscle Is Not a Passive Target in Myasthenia Gravis"],"prefix":"10.3389","volume":"10","author":[{"given":"Jean-Thomas","family":"Vilquin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Clarissa","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1056\/NEJM197510092931508","article-title":"Acetylcholine receptor antibodies in myasthenia gravis","volume":"293","author":"Appel","year":"1975","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0928-4257(98)80004-1","article-title":"Development of the neuromuscular junction: genetic analysis in mice","volume":"92","author":"Sanes","year":"1998","journal-title":"J Physiol Paris."},{"key":"B4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.13502","article-title":"Diagnostic utility of cortactin antibodies in myasthenia gravis","volume":"1412","author":"Illa","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: Paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2017.07.006","article-title":"Pathophysiology and immunological profile of myasthenia gravis and its subgroups","volume":"49","author":"Romi","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve."},{"key":"B13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Prim."},{"key":"B14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis - a comprehensive review","volume":"52","author":"Avidan","year":"2013","journal-title":"J Autoimmun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/joim.12163","article-title":"Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis","volume":"275","author":"Huijbers","year":"2014","journal-title":"J Intern Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"JF. Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"40624","DOI":"10.1074\/jbc.M111.279307","article-title":"Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK)","volume":"286","author":"Zhang","year":"2011","journal-title":"J Biol Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To build a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"Wu","year":"2010","journal-title":"Development."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis","volume":"312","author":"Okada","year":"2006","journal-title":"Science."},{"key":"B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/bja\/aep150","article-title":"Current concepts in neuromuscular transmission","volume":"103","author":"Fagerlund","year":"2009","journal-title":"Br J Anaesth."},{"key":"B23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1152\/physrev.00033.2014","article-title":"Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting","volume":"95","author":"Tintignac","year":"2015","journal-title":"Physiol Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E2183","DOI":"10.3390\/ijms18102183","article-title":"The structure of human neuromuscular junctions: some unanswered molecular questions","volume":"18","author":"Slater","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ncl.2018.01.009","article-title":"Practical anatomy of the neuromuscular junction in health and disease","volume":"36","author":"Nishimune","year":"2018","journal-title":"Neurol Clin."},{"key":"B26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2741\/4532","article-title":"Trans-synaptic homeostasis at the myasthenic neuromuscular junction","volume":"22","author":"Plomp","year":"2017","journal-title":"Front Biosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jnnp.43.7.577","article-title":"Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes","volume":"43","author":"Engel","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.04.038","article-title":"How myasthenia gravis alters the safety factor for neuromuscular transmission","author":"Ruff","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/nyas.13507","article-title":"Neuromuscular synapse electrophysiology in myasthenia gravis animal models","volume":"1412","author":"Plomp","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1749-6632.2012.06841.x","article-title":"Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles: safety factor in ocular myasthenia","volume":"1275","author":"Serra","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1196\/annals.1405.037","article-title":"Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?","volume":"1132","author":"Soltys","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1084\/jem.144.3.726","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. I. immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune m","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J Exp Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0022-510X(88)90006-8","article-title":"Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. correlations with clinical state","volume":"86","author":"Eymard","year":"1988","journal-title":"J Neurol Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e114060","DOI":"10.1371\/journal.pone.0114060","article-title":"Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development","volume":"9","author":"Heldal","year":"2014","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","article-title":"Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis","volume":"39","author":"Sahashi","year":"1980","journal-title":"J Neuropathol Exp Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.410430315","article-title":"End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis","volume":"43","author":"Ruff","year":"1998","journal-title":"Ann Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e12658","DOI":"10.14814\/phy2.12658","article-title":"Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis","volume":"3","author":"Ghazanfari","year":"2015","journal-title":"Physiol Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J Clin Invest."},{"key":"B44","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J Autoimmun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneuroim.2012.09.001","article-title":"Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis","volume":"254","author":"Takamori","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2018.01.015","article-title":"Induction of anti-agrin antibodies causes myasthenia gravis in mice","volume":"373","author":"Yan","year":"2018","journal-title":"Neuroscience."},{"key":"B53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nmd.2019.03.009","article-title":"A review of the histopathological findings in myasthenia gravis: clues to the pathogenesis of treatment-resistance in extraocular muscles","volume":"29","author":"Europa","year":"2019","journal-title":"Neuromuscul Disord."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","article-title":"IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis","volume":"3","author":"Maurer","year":"2015","journal-title":"Acta Neuropathol Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0022-510X(98)00181-6","article-title":"Cytokine and chemokine mRNA expressing cells in muscle tissues of experimental autoimmune myasthenia gravis","volume":"161","author":"Li","year":"1998","journal-title":"J Neurol Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.4049\/jimmunol.169.3.1579","article-title":"Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattractant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis","volume":"169","author":"Reyes-Reyna","year":"2002","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0165-5728(01)00401-5","article-title":"Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis","volume":"119","author":"Stegall","year":"2001","journal-title":"J Neuroimmunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0165-5728(01)00414-3","article-title":"Acetylcholine receptor-reactive antibody induces nitric oxide production by a rat skeletal muscle cell line: influence of cytokine environment","volume":"120","author":"Garcia","year":"2001","journal-title":"J Neuroimmunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2018.09.012","article-title":"Programmed cell death ligand 1 expression is upregulated in the skeletal muscle of patients with myasthenia gravis","volume":"325","author":"Iwasa","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of myasthenia gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve."},{"key":"B63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/sji.12057","article-title":"Expression of Interleukin-22 in myasthenia gravis","volume":"78","author":"Zheng","year":"2013","journal-title":"Scand J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"39716","DOI":"10.1038\/srep39716","article-title":"Profile of upregulated inflammatory proteins in sera of myasthenia gravis patients","volume":"7","author":"Molin","year":"2017","journal-title":"Sci Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0165-5728(01)00287-9","article-title":"Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts","volume":"116","author":"Marino","year":"2001","journal-title":"J Neuroimmunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/clim.1999.4822","article-title":"Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis","volume":"94","author":"Stegall","year":"2000","journal-title":"Clin Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/gt.2010.124","article-title":"Skeletal muscle cells: from local inflammatory response to active immunity","volume":"18","author":"Marino","year":"2011","journal-title":"Gene Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12035-008-8039-7","article-title":"Regulation of synaptic transmission by presynaptic CaMKII and BK channels","volume":"38","author":"Wang","year":"2008","journal-title":"Mol Neurobiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1113\/jphysiol.1996.sp021373","article-title":"Involvement of protein kinases in the upregulation of acetylcholine release at endplates of \u03b1-bungarotoxin-treated rats","volume":"493","author":"Plomp","year":"1996","journal-title":"J Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuroscience.2005.11.040","article-title":"Alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction","volume":"138","author":"Sons","year":"2006","journal-title":"Neuroscience."},{"key":"B72","doi-asserted-by":"publisher","first-page":"18332","DOI":"10.1073\/pnas.0608507103","article-title":"Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size","volume":"103","author":"Toonen","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"12188","DOI":"10.1038\/ncomms12188","article-title":"LRRK2 regulates retrograde synaptic compensation at the drosophila neuromuscular junction","volume":"7","author":"Penney","year":"2016","journal-title":"Nat Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1523\/JNEUROSCI.3786-15.2016","article-title":"Reversible recruitment of a homeostatic reserve pool of synaptic vesicles underlies rapid homeostatic plasticity of quantal content","volume":"36","author":"Wang","year":"2016","journal-title":"J Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature."},{"key":"B76","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0014-5793(88)80442-3","article-title":"Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis","volume":"233","author":"Asher","year":"1988","journal-title":"FEBS Lett."},{"key":"B78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0014-5793(90)80932-9","article-title":"Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis","volume":"267","author":"Asher","year":"1990","journal-title":"FEBS Lett."},{"key":"B79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0014-5793(92)80089-Y","article-title":"Changes in the expression of mRNAs for myogenic factors and other muscle-specific proteins in experimental autoimmune myasthenia gravis","volume":"299","author":"Asher","year":"1992","journal-title":"FEBS Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/JCI117302","article-title":"Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction","volume":"94","author":"Guyon","year":"1994","journal-title":"J Clin Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J Clin Invest."},{"key":"B82","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jss.2019.04.056","article-title":"Two pathways regulate differential expression of nAChRs between the orbicularis oris and gastrocnemius","volume":"243","author":"Wu","year":"2019","journal-title":"J Surg Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jneuroim.2016.10.011","article-title":"Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis","volume":"301","author":"Iwasa","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneuroim.2014.05.006","article-title":"Increased skeletal muscle expression of the endoplasmic reticulum chaperone GRP78 in patients with myasthenia gravis","volume":"273","author":"Iwasa","year":"2014","journal-title":"J Neuroimmunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/08916934.2017.1367772","article-title":"Decreased bone mineral density in experimental myasthenia gravis in C57BL\/6 mice","volume":"50","author":"Oshima","year":"2017","journal-title":"Autoimmunity."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1167\/iovs.14-14422","article-title":"RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment","volume":"55","author":"Zhou","year":"2014","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2018.10.006","article-title":"Orienting muscle stem cells for regeneration in homeostasis, aging, and disease","volume":"23","author":"Feige","year":"2018","journal-title":"Cell Stem Cell."},{"key":"B88","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00401-017-1754-2","article-title":"Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration","volume":"134","author":"Attia","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.stem.2015.10.002","article-title":"Functional connectivity under optogenetic control allows modeling of human neuromuscular disease","volume":"18","author":"Steinbeck","year":"2016","journal-title":"Cell Stem Cell."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e44530","DOI":"10.7554\/eLife.44530","article-title":"A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction","volume":"8","author":"Afshar Bakooshli","year":"2019","journal-title":"Elife."},{"key":"B91","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:49:41Z","timestamp":1576730981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":91,"alternative-id":["10.3389\/fneur.2019.01343"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01343","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"article-number":"1343"}}